• Core Technology: Adopts microfluidic chip and PCR-dot blot hybridization technology, enabling fully automatic and closed detection with a "sample-in, result-out" workflow.
• Main Application: Qualitatively detect 24/28 subtypes of human papillomavirus (HPV) in cervical samples. Can be extended to respiratory/gastrointestinal pathogens and human drug resistance genes.
• Structural Features: The main machine integrates image display, reagent addition, and temperature control. The touch screen runs a Windows system for visual operation and data monitoring.
• Clinical Advantages: Fully closed process reduces contamination risks. Automatic operation improves efficiency for hospital clinical laboratories and third-party medical labs.

Background: HPV is the main cause of sexually transmitted infections, responsible for >90% of cervical cancer cases. Persistent infection with high-risk types (HPV 16, 18, 45, and 31) accounts for 80% of cervical intraepithelial neoplasia.